NO20001810L - 8-azabicyklo [3.2.1] oktan-3-metanaminderivater som ligander av D2 og D3 dopamin- og 5HT1A og 5HT2 serotoninreseptorer - Google Patents

8-azabicyklo [3.2.1] oktan-3-metanaminderivater som ligander av D2 og D3 dopamin- og 5HT1A og 5HT2 serotoninreseptorer

Info

Publication number
NO20001810L
NO20001810L NO20001810A NO20001810A NO20001810L NO 20001810 L NO20001810 L NO 20001810L NO 20001810 A NO20001810 A NO 20001810A NO 20001810 A NO20001810 A NO 20001810A NO 20001810 L NO20001810 L NO 20001810L
Authority
NO
Norway
Prior art keywords
5ht1a
azabicyclo
dopamine
octane
ligands
Prior art date
Application number
NO20001810A
Other languages
English (en)
Other versions
NO325170B1 (no
NO20001810D0 (no
Inventor
Beno T Marabout
Mireille Sevrin
Pascal George
Jean-Pierre Merly
Daniele De Peretti
Jocelyne Roy
David Machnik
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9712580A external-priority patent/FR2769628B1/fr
Priority claimed from FR9712583A external-priority patent/FR2769629B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20001810D0 publication Critical patent/NO20001810D0/no
Publication of NO20001810L publication Critical patent/NO20001810L/no
Publication of NO325170B1 publication Critical patent/NO325170B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20001810A 1997-10-09 2000-04-07 8-azabicyklo [3.2.1] oktan-3-metanaminderivater, medikamenter og farmasoytiske preparater NO325170B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9712580A FR2769628B1 (fr) 1997-10-09 1997-10-09 Derives de n-(2,3-dihydro-1h-inden-2-yl)-n-propyl-8- azabicyclo[3.2.1.]octane-3-methanamine, leur preparation et leur application en therapeutique
FR9712583A FR2769629B1 (fr) 1997-10-09 1997-10-09 Derives de 8-azabicyclo[3.2.1]octane-3-methanamine, leur preparation et leur application en therapeutique
PCT/FR1998/002137 WO1999019325A1 (fr) 1997-10-09 1998-10-07 Derives de 8-azabicyclo [3.2.1] octane-3-methanamine en tant que ligands des recepteurs de dopamine d2 et d3 et de serotonine 5ht1a et 5ht2

Publications (3)

Publication Number Publication Date
NO20001810D0 NO20001810D0 (no) 2000-04-07
NO20001810L true NO20001810L (no) 2000-06-09
NO325170B1 NO325170B1 (no) 2008-02-11

Family

ID=26233854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001810A NO325170B1 (no) 1997-10-09 2000-04-07 8-azabicyklo [3.2.1] oktan-3-metanaminderivater, medikamenter og farmasoytiske preparater

Country Status (31)

Country Link
US (1) US6221879B1 (no)
EP (1) EP1021442B1 (no)
JP (1) JP4505135B2 (no)
KR (1) KR20010015717A (no)
CN (1) CN1140526C (no)
AR (1) AR017300A1 (no)
AT (1) ATE212631T1 (no)
AU (1) AU746935B2 (no)
BG (1) BG64859B1 (no)
BR (1) BR9812752A (no)
CA (1) CA2305468C (no)
CO (1) CO5011097A1 (no)
CZ (1) CZ290679B6 (no)
DE (1) DE69803689T2 (no)
DK (1) DK1021442T3 (no)
EE (1) EE04347B1 (no)
ES (1) ES2171306T3 (no)
HK (1) HK1029108A1 (no)
HU (1) HUP0102086A3 (no)
IL (2) IL135520A0 (no)
NO (1) NO325170B1 (no)
NZ (1) NZ503829A (no)
PL (1) PL186998B1 (no)
PT (1) PT1021442E (no)
RU (1) RU2203281C2 (no)
SI (1) SI1021442T1 (no)
SK (1) SK283080B6 (no)
TR (1) TR200000942T2 (no)
TW (1) TW444014B (no)
UA (1) UA58476C2 (no)
WO (1) WO1999019325A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
ATE520659T1 (de) * 2004-10-14 2011-09-15 Abbott Gmbh & Co Kg Zur behandlung von auf die modulation des dopamin-d3-rezeptors ansprechenden erkrankungen geeignete azabicycloheptylverbindungen
WO2006089053A2 (en) 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
AU2011225095C1 (en) 2010-03-11 2017-01-19 Sumitomo Dainippon Pharma Co., Ltd. N-Acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
DK3230255T3 (da) 2014-12-09 2020-06-22 Ezekiel Golan Regulatorer af uhæmmet adfærd
EP3230256B1 (en) * 2014-12-09 2019-11-13 Ezekiel Golan Alcoholic beverage substitutes
KR102128782B1 (ko) 2018-09-20 2020-07-01 한양대학교 에리카산학협력단 트로페인(Tropane) 알칼로이드 화합물 및 순차적 산화반응을 이용한 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
JPS5592384A (en) * 1978-12-30 1980-07-12 Beecham Group Ltd Compound having pharmacological activity
IL61642A0 (en) * 1979-12-20 1981-01-30 Beecham Group Ltd Aniline derivatives,their preparation and pharmalceutical compositions containing them
US4910302A (en) 1988-12-19 1990-03-20 American Home Products Corporation Psychotropic polycyclic imides
FR2659323B1 (fr) * 1990-03-07 1992-06-12 Synthelabo Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
FR2681320B1 (fr) * 1991-09-12 1994-01-14 Synthelabo Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
FR2702211B1 (fr) * 1993-03-04 1995-06-02 Pf Medicament Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
SI1021442T1 (en) 2002-08-31
AU9446898A (en) 1999-05-03
HUP0102086A2 (hu) 2001-12-28
NO325170B1 (no) 2008-02-11
US6221879B1 (en) 2001-04-24
NO20001810D0 (no) 2000-04-07
EP1021442B1 (fr) 2002-01-30
KR20010015717A (ko) 2001-02-26
HUP0102086A3 (en) 2002-09-30
EE200000207A (et) 2001-04-16
AU746935B2 (en) 2002-05-09
EE04347B1 (et) 2004-08-16
IL135520A0 (en) 2001-05-20
CO5011097A1 (es) 2001-02-28
PL186998B1 (pl) 2004-04-30
JP2001519431A (ja) 2001-10-23
DE69803689D1 (de) 2002-03-14
EP1021442A1 (fr) 2000-07-26
IL135520A (en) 2007-07-24
PT1021442E (pt) 2002-06-28
DK1021442T3 (da) 2002-05-13
ES2171306T3 (es) 2002-09-01
SK283080B6 (sk) 2003-02-04
BG64859B1 (bg) 2006-07-31
CZ20001278A3 (cs) 2000-07-12
CN1140526C (zh) 2004-03-03
CN1281455A (zh) 2001-01-24
CZ290679B6 (cs) 2002-09-11
CA2305468C (en) 2007-09-25
SK5042000A3 (en) 2001-03-12
BR9812752A (pt) 2000-08-29
BG104309A (en) 2001-05-31
AR017300A1 (es) 2001-09-05
DE69803689T2 (de) 2002-10-10
NZ503829A (en) 2002-03-28
HK1029108A1 (en) 2001-03-23
TR200000942T2 (tr) 2000-09-21
RU2203281C2 (ru) 2003-04-27
ATE212631T1 (de) 2002-02-15
JP4505135B2 (ja) 2010-07-21
WO1999019325A1 (fr) 1999-04-22
CA2305468A1 (en) 1999-04-22
PL339764A1 (en) 2001-01-02
TW444014B (en) 2001-07-01
UA58476C2 (uk) 2003-08-15

Similar Documents

Publication Publication Date Title
FI973205A (fi) Indolijohdannaisia 5-HT-reseptoriantagonisteina
DK1140828T3 (da) 3-Azabicyclo[3.1.0]hexan-derivater som opiat-receptorligander
NO985242D0 (no) Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer
EP0707581A1 (en) INDOLINE DERIVATIVES AS 5 HT2C ANTAGONISTS
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
PL336628A1 (en) Derivatives of tetrahydroisoquinoline as modulators of d3 dopamine receptors
AU7284096A (en) Heterocyclically-substituted 1-indole carboxamides as cyclo-oxygenase-2 inhibitors
FI961628A (fi) Indolijohdannaisia NMDA-antagonisteina
AU6435594A (en) Indole derivatives as dopamine d4 antagonists
AU6343998A (en) Constitutively activated serotonin receptors
NO974043D0 (no) Indolderivater som EAA-antagonister
PL311266A1 (en) Application of indole derivatives as 5ht1 antagonists
NO20001810L (no) 8-azabicyklo [3.2.1] oktan-3-metanaminderivater som ligander av D2 og D3 dopamin- og 5HT1A og 5HT2 serotoninreseptorer
AU8743098A (en) Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
NO985970D0 (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
AU6215794A (en) Indole derivatives as dopamine d4 antagonists
DK0725061T3 (da) Substituerede indolderivater
DK0885222T3 (da) Heterocycliske ergolinderivater som 5HT1A-receptorligander
AU1809595A (en) Phenylpyrrole derivatives and their use as dopamine d3 antagonists
AU7578596A (en) Substituted piperidine derivatives as selective agonists of 5-ht receptors
ZA983659B (en) Tetrahydroisoquinoline derivatives as modulators of Dopamine D3 Receptors.
ZA974026B (en) Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees